XCyton Diagnostics
Provider of molecular diagnostic testing and diagnostic product development focused on rapid, syndrome-based multiplex detection of pathogens for critical-care infections. Operates R&D and production facilities with biosafety containment, develops molecular and immunodiagnostic assays, and offers laboratory testing services and decision-support for clinicians.
Industries
Nr. of Employees
small (1-50)
Products
Syndrome-based multiplex diagnostic platform
A multiplex molecular diagnostic platform designed to amplify and hybridize syndrome-specific signature genes to detect multiple pathogens from a single clinical sample and support therapeutic decision-making.
Immunoassay kits (ELISA)
Immunoassay kits developed for serological detection of infectious diseases (historical product development and manufacture).
XCyto Screen
For simultaneous detection of and differentiation between Gram positive and Gram negative bacteria, Filamentous and Non filamentous fungi and Mycobacterium tuberculosis.
XCyto Screen Encephalitis
For simultaneous detection of Herpes simplex Virus, Cytomegalo Virus, Varicella Zoster Virus, Mycobacterium tuberculosis, Toxoplasma gondii and Filamentous and Non filamentous fungi.
XCyto Screen Viral Retinitis
For simultaneous detection of Herpes simplex Virus, Cytomegalo Virus and Varicella Zoster Virus.
XCyto Screen KeratoConjunctivitis
For simultaneous detection of Herpes simplex Virus, Adenovirus and Chlamydia trachomatis.
Syndrome-based multiplex diagnostic platform
A multiplex molecular diagnostic platform designed to amplify and hybridize syndrome-specific signature genes to detect multiple pathogens from a single clinical sample and support therapeutic decision-making.
Immunoassay kits (ELISA)
Immunoassay kits developed for serological detection of infectious diseases (historical product development and manufacture).
XCyto Screen
For simultaneous detection of and differentiation between Gram positive and Gram negative bacteria, Filamentous and Non filamentous fungi and Mycobacterium tuberculosis.
XCyto Screen Encephalitis
For simultaneous detection of Herpes simplex Virus, Cytomegalo Virus, Varicella Zoster Virus, Mycobacterium tuberculosis, Toxoplasma gondii and Filamentous and Non filamentous fungi.
XCyto Screen Viral Retinitis
For simultaneous detection of Herpes simplex Virus, Cytomegalo Virus and Varicella Zoster Virus.
XCyto Screen KeratoConjunctivitis
For simultaneous detection of Herpes simplex Virus, Adenovirus and Chlamydia trachomatis.
Services
Laboratory testing service offering syndrome-based multiplex molecular assays for identification of multiple pathogens from a single specimen to support rapid clinical management of critical-care infections.
Laboratory testing service offering syndrome-based multiplex molecular assays for identification of multiple pathogens from a single specimen to support rapid clinical management of critical-care infections.
Expertise Areas
- Molecular diagnostic assay development
- Multiplex pathogen panel design
- Clinical laboratory testing for critical-care infections
- Diagnostic product development and translation
Key Technologies
- Multiplex PCR / rapid multiplex amplification
- Hybridization-based detection of amplified targets
- DNA-based pathogen detection
- Molecular antimicrobial resistance gene detection
News & Updates
Award recognizing technology developed in Asia (listed for 2009).
Biospectrum Best Bio-Product Award for the Syndrome Evaluation System.
Biospectrum Best Bio-Product Award for an immunodiagnostic product (listed for 2004).
Award recognizing technology developed in Asia (listed for 2009).
Biospectrum Best Bio-Product Award for the Syndrome Evaluation System.
Biospectrum Best Bio-Product Award for an immunodiagnostic product (listed for 2004).